Modafinil
- Product NDC
- 70710-1073
- 11-digit product format
- 707101073
- Labeler code
- 70710
- Product ID
- 70710-1073_3cf01722-3fed-4829-a95f-3822782b6d8d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Modafinil
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Application
- ANDA209966
- Marketing category
- ANDA
- Marketing start
- 2018-01-04
- Marketing end
- 0000-00-00
- Substance
- MODAFINIL
- Active strength
- 200 mg/1
- Pharmacologic classes
- Central Nervous System Stimulation [PE],Increased Sympathetic Activity [PE],Sympathomimetic-like Agent [EPC]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70710-1073-1 | 2022-07-09 | C162847 | 48780-1 | 9d75b9d1-1f02-f424-e053-dadaa90a57ce | 7b3f0383-895e-4fcd-bce4-362678424005 |
| 70710-1073-3 | 2022-07-09 | C162847 | 48780-1 | 9d75b9d1-1f02-f424-e053-dadaa90a57ce | 7b3f0383-895e-4fcd-bce4-362678424005 |
| 70710-1073-9 | 2022-07-09 | C162847 | 48780-1 | 9d75b9d1-1f02-f424-e053-dadaa90a57ce | 7b3f0383-895e-4fcd-bce4-362678424005 |
| 70710-1073-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-1f02-f424-e053-dadaa90a57ce | 7b3f0383-895e-4fcd-bce4-362678424005 |
| 70710-1073-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-1f02-f424-e053-dadaa90a57ce | 7b3f0383-895e-4fcd-bce4-362678424005 |
| 70710-1073-9 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-1f02-f424-e053-dadaa90a57ce | 7b3f0383-895e-4fcd-bce4-362678424005 |